{"organizations": [], "uuid": "0f7f0d066780f7355b9551edd3a1a97465cc3932", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2018/01/08/104934778-2ED2-MM-Block-D-010818.600x400.jpg", "site_section": "http://www.cnbc.com/id/10001135/device/rss/rss.html", "section_title": "Stock Picks", "url": "https://www.cnbc.com/video/2018/01/08/alkermes-ceo-our-opioid-addiction-treatment-has-best-days-ahead.html", "country": "US", "domain_rank": 767, "title": "'Best days are still ahead' for top opioid addiction treatment Vivitrol, CEO says", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "blogs", "published": "2018-01-09T01:55:00.000+02:00", "replies_count": 0, "uuid": "0f7f0d066780f7355b9551edd3a1a97465cc3932"}, "author": "", "url": "https://www.cnbc.com/video/2018/01/08/alkermes-ceo-our-opioid-addiction-treatment-has-best-days-ahead.html", "ord_in_thread": 0, "title": "'Best days are still ahead' for top opioid addiction treatment Vivitrol, CEO says", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "'Best days are still ahead' for top opioid addiction treatment Vivitrol, CEO says 2 Hours Ago Jim Cramer spoke to Alkermes CEO Richard Pops, who said 2018 will be a year of milestones for his company's drugs.", "external_links": [], "published": "2018-01-09T01:55:00.000+02:00", "crawled": "2018-01-09T10:14:29.961+02:00", "highlightTitle": ""}